These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 52828

  • 41. [Management of supraventricular and ventricular arrhythmias with the intravenous administration of the calcium antagonist Tiapamil (Ro 11-1781) (author's transl)].
    Menzel T, Kirchner P, Cocco G, Gasser DF.
    Z Kardiol; 1981 Mar; 70(3):163-71. PubMed ID: 6165153
    [Abstract] [Full Text] [Related]

  • 42. [Value of propafenon in the control of ventricular extrasystolic arrhythmia. Clinical, electrocardiographic and laboratory evaluation in prolonged use].
    Giannini SD, Zillioto EE, Campanari JC, Formicola A.
    Arq Bras Cardiol; 1980 Dec; 35(6):525-8. PubMed ID: 6167246
    [No Abstract] [Full Text] [Related]

  • 43. [Therapy of ventricular tachyarrhythmias refractory to lidocaine with propafenone (author's transl)].
    Laimer H, Glogar D, Zilcher H.
    Acta Med Austriaca; 1981 Dec; 8(5):140-4. PubMed ID: 7331741
    [Abstract] [Full Text] [Related]

  • 44. [Effect of a single oral dose of allapinin in patients with chronic ventricular extrasystole].
    Sokolov SF, Alikhanov GN, Golitsyn SP, Koltunova MI, Smetnev AS.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989 Dec; 12(1):36-42. PubMed ID: 2472819
    [Abstract] [Full Text] [Related]

  • 45. [Acute and long-term antiarrhythmia effect of encainide in chronic atrial extrasystole].
    Thale J, Klein H, Shanks RG, Bender F.
    Z Kardiol; 1985 Apr; 74(4):220-7. PubMed ID: 2408392
    [Abstract] [Full Text] [Related]

  • 46. [Effectiveness of intravenous infusion of ethmozin in patients with chronic ventricular arrhythmias].
    Merkulova IN, Piotrovskiĭ VK, Metelitsa VI, Romina IN, Blank ML.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989 Apr; 12(1):25-31. PubMed ID: 2472818
    [Abstract] [Full Text] [Related]

  • 47. [Electrophysiologic and anti-arrhythmia properties of propafenone deducible from experimental studies in vitro].
    Ledda F, Mantelli L.
    G Ital Cardiol; 1984 Apr; 14(4):279-84. PubMed ID: 6329868
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Medical management of tachycardias (author's transl)].
    Petri H, Rudolph W.
    Herz; 1979 Aug; 4(4):344-58. PubMed ID: 93075
    [Abstract] [Full Text] [Related]

  • 50. [Use of plasmapheresis in the treatment of drug-resistant cardiac arrhythmias].
    Nedostup AV, Tsaregorodtsev DA, Ragimov AA, Solov'eva IN, Alekseeva LA, Andrianova MIu, Paliulina MV, Mil'chakov VI, Svirshchevskiĭ EB, Adrianov SO, Smolianitskiĭ AIa, Egorova TD.
    Ter Arkh; 2002 Aug; 74(12):41-6. PubMed ID: 12577839
    [Abstract] [Full Text] [Related]

  • 51. [Hemodynamic effects of propafenone in acute myocardial infarct].
    Finzi A, Ambrosini F, Pagnoni F, Massari FM, Valentini R, Lotto A.
    G Ital Cardiol; 1984 May; 14(5):367-72. PubMed ID: 6468818
    [Abstract] [Full Text] [Related]

  • 52. [Plasma level studies of quinidine retard, their significance for dosage and onset of effect].
    Guckenbiehl W, Just H, Olbermann M, Lang KF.
    Med Klin; 1976 Apr 02; 71(14):586-92. PubMed ID: 57566
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Mexiletine in the treatment of ventricular arrhythmias (author's transl)].
    Schlemmer M, Wimmer M.
    Padiatr Padol; 1982 Apr 02; 17(2):383-9. PubMed ID: 6179031
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Cholestasis after antiarrhythmic therapy with propafenone].
    Konz KH, Berg PA, Seipel L.
    Dtsch Med Wochenschr; 1984 Oct 05; 109(40):1525-7. PubMed ID: 6206993
    [Abstract] [Full Text] [Related]

  • 58. Oral propafenone in the suppression of chronic stable ventricular arrhythmias.
    Schamroth L, Myburgh DP, Schamroth CL, Scholtz ME, Pincus DR, Kawalsky DL.
    Chest; 1985 Apr 05; 87(4):448-51. PubMed ID: 3884286
    [Abstract] [Full Text] [Related]

  • 59. Clinical evaluation of new antiarrhythmic agents: experiences with propafenone.
    Furlanello F, Disertori M, Vergara G, Guarnerio M, Dal Forno P, Padrini R, Gobbato S, Ferrari M.
    Int J Clin Pharmacol Res; 1983 Apr 05; 3(2):101-5. PubMed ID: 6679511
    [Abstract] [Full Text] [Related]

  • 60. [Evaluation of propafenon in Chagas patients with ventricular extrasystole].
    da Silva MA, Fragata Filho AA, Boainain E, Magalhães HM.
    Arq Bras Cardiol; 1981 Jun 05; 36(6):437-40. PubMed ID: 6180714
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.